Skip to main content

Advertisement

Log in

Evaluation of Relationship Between SOD1 50-bp Deletion Gene Polymorphism, Cu, Zn Level, and Viscosity in Postmenopausal Osteoporosis Patients with Vertebral Fractures

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Oxidative stress plays a role in the pathogenesis of bone loss, causing low bone mineral density (BMD) and associated osteoporotic fractures. In our study, we aimed to investigate the relationship of SOD1 50-bp insertion(Ins)/deletion(Del) polymorphism that is involved in oxidative stress metabolism, Cu and Zn element concentrations, and plasma viscosity level, with postmenopausal osteoporosis and related vertebral fractures. The study included 167 voluntary individuals. The 50-bp Ins/Del polymorphism of SOD1 was determined by allele-specific PCR. Plasma Cu and Zn levels were measured by atomic absorption spectrophotometry (AAS). The plasma viscosity was determined using the Harkness Capillary Viscometer device. In our study, the distribution of SOD1 promoter 50-bp Ins/Del polymorphism did not indicate a significant difference between the groups and in postmenopausal osteoporosis patients with and without fractures (p > 0.05). The Ins/Ins genotype was found to be common in individuals in both groups. The Cu and Zn levels of the study group were found to be between the normal reference values (p > 0.05). It was determined that plasma viscosity increased significantly in the group of osteoporotic patients and in patients with postmenopausal osteoporosis with fractures (p < 0.01). In addition, plasma viscosity was found to significantly increase in patients with Ins/Ins genotype and fractures (p < 0.01). Postmenopausal osteoporosis and associated vertebral fracture were found not to be directly related to SOD1 50-bp polymorphism and Cu and Zn element levels. Plasma viscosity levels were found to increase due to the increase in oxidative stress products. Further studies are needed to clarify the roles and relationships of SOD genes and trace elements in the development of postmenopausal osteoporosis and vertebral fracture.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D (1997) Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 7:390–406

    Article  CAS  Google Scholar 

  2. Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM (2018) A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag 14:2029

    Article  CAS  Google Scholar 

  3. Sözen T, Özışık L, Başaran NÇ (2017) An overview and management of osteoporosis. Eur J Rheumatol 4:46

    Article  Google Scholar 

  4. Barnsley J, Buckland G, Chan PE, Ong A, Ramos AS, Baxter M, Laskou F, Dennison EM, Cooper C, Patel HP (2021) Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people. Aging Clin Exp Res 33:759–773

    Article  CAS  Google Scholar 

  5. Ferrari S (2005) Osteoporosis: a complex disorder of aging with multiple genetic and environmental determinants. World Rev Nutr Diet 95:35

    Article  CAS  Google Scholar 

  6. Botre C, Shahu A, Adkar N, Shouche Y, Ghaskadbi S, Ashma R (2015) Superoxide dismutase 2 polymorphisms and osteoporosis in Asian Indians: a genetic association analysis. Cell Mol Biol Lett 20:685–697

    Article  CAS  Google Scholar 

  7. Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ (2003) A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112:915–923

    Article  CAS  Google Scholar 

  8. Baek KH, Oh KW, Lee WY, Lee SS, Kim MK, Kwon HS, Rhee EJ, Han JH, Song KH, Cha BY (2010) Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures. Calcif Tissue Int 87:226–235

    Article  CAS  Google Scholar 

  9. Agidigbi TS, Kim C (2019) Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases. Int J Mol Sci 20:3576

    Article  CAS  Google Scholar 

  10. Basu S, Michaëlsson K, Olofsson H, Johansson S, Melhus H (2001) Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 288:275–279

    Article  CAS  Google Scholar 

  11. Fukai T, Ushio-Fukai M (2011) Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 15:1583–1606

    Article  CAS  Google Scholar 

  12. Juarez JC, Manuia M, Burnett ME, Betancourt O, Boivin B, Shaw DE, Tonks NK, Mazar AP, Doñate F (2008) Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc Natl Acad Sci 105:7147–7152

    Article  CAS  Google Scholar 

  13. Carlström M, Lai EY, Ma Z, Steege A, Patzak A, Eriksson UJ, Lundberg JO, Wilcox CS, Persson AEG (2010) Superoxide dismutase 1 limits renal microvascular remodeling and attenuates arteriole and blood pressure responses to angiotensin II via modulation of nitric oxide bioavailability. Hypertension 56:907–913

    Article  Google Scholar 

  14. Neves AL, Mohammedi K, Emery N, Roussel R, Fumeron F, Marre M, Velho G (2012) Allelic variations in superoxide dismutase-1 (SOD1) gene and renal and cardiovascular morbidity and mortality in type 2 diabetic subjects. Mol Genet Metab 106:359–365

    Article  CAS  Google Scholar 

  15. Milani P, Gagliardi S, Bongioanni P, Grieco GS, Dezza M, Bianchi M, Cova E, Ceroni M, Cereda C (2012) Effect of the 50 bp deletion polymorphism in the SOD1 promoter on SOD1 mRNA levels in Italian ALS patients. J Neurol Sci 313:75–78

    Article  CAS  Google Scholar 

  16. Milani P, Gagliardi S, Cova E, Cereda C (2011) SOD1 transcriptional and posttranscriptional regulation and its potential implications in ALS. Neurol Res Int 1:1–9

    Article  Google Scholar 

  17. Nojiri H, Saita Y, Morikawa D, Kobayashi K, Tsuda C, Miyazaki T, Saito M, Marumo K, Yonezawa I, Kaneko K (2011) Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking. J Bone Miner Res 26:2682–2694

    Article  CAS  Google Scholar 

  18. Morikawa D, Nojiri H, Saita Y, Kobayashi K, Watanabe K, Ozawa Y, Koike M, Asou Y, Takaku T, Kaneko K (2013) Cytoplasmic reactive oxygen species and SOD1 regulate bone mass during mechanical unloading. J Bone Miner Res 28:2368–2380

    Article  CAS  Google Scholar 

  19. Mlakar SJ, Osredkar J, Prezelj J, Marc J (2012) Antioxidant enzymes GSR, SOD1, SOD2, and CAT gene variants and bone mineral density values in postmenopausal women: a genetic association analysis. Menopause 19:368–376

    Article  Google Scholar 

  20. Deng F, Lei S, Chen X, Tan L, Zhu X, Deng H (2011) An integrative study ascertained SOD2 as a susceptibility gene for osteoporosis in Chinese. J Bone Miner Res 26:2695–2701

    Article  Google Scholar 

  21. Sarabandi S, Effatpanah H, Sereshki N, Samavarchi Tehrani S, Moradi-Sardareh H (2021) 50-bp insertion/deletion polymorphism of the superoxide dismutase-1 is associated with bladder cancer risk in an Iranian population. Nucleosides Nucleotides Nucleic Acids 1–12

  22. Namdari S, Saadat M (2021) Susceptibility to preeclampsia is associated with a 50-bp insertion/deletion polymorphism at the promoter region of the SOD1 gene. J Turkish Ger Gynecol Assoc 22:268

    Article  CAS  Google Scholar 

  23. Eskandari-Nasab E, Kharazi-Nejad E, Nakhaee A, Afzali M, Tabatabaei SP, Tirgar-Fakheri K, Hashemi M (2014) 50-bp Ins/Del polymorphism of SOD1 is associated with increased risk of cardiovascular disease. Acta Med Iran 52:591–595

    Google Scholar 

  24. Kordestanian N, Saadat M (2017) A 50-bp Ins/Del polymorphism at the promoter region of the superoxide dismutase-1 and bipolar disorder type 1. Nord J Psychiatry 71:570–573

    Article  Google Scholar 

  25. Aaseth J, Boivin G, Andersen O (2012) Osteoporosis and trace elements–an overview. J Trace Elem Med Biol 26:149–152

    Article  CAS  Google Scholar 

  26. Moioli C, Tagliabue L, Cioni F (2018) Osteoporosis and mineral nutrition. A literature review. Prog Nutr 20:305–312

    Google Scholar 

  27. Saltman PD, Strause LG (1993) The role of trace minerals in osteoporosis. J Am Coll Nutr 12:384–389

    Article  CAS  Google Scholar 

  28. Liu S-Z, Yan H, Xu P, Li J-P, Zhuang G-H, Zhu B-F, Lu S-M (2009) Correlation analysis between bone mineral density and serum element contents of postmenopausal women in Xi’an urban area. Biol Trace Elem Res 131:205–214

    Article  CAS  Google Scholar 

  29. Nieves JW (2005) Osteoporosis: the role of micronutrients. Am J Clin Nutr 81:1232S-1239S

    Article  CAS  Google Scholar 

  30. Strain JJ (1988) A reassessment of diet and osteoporosis—possible role for copper. Med Hypotheses 27:333–338

    Article  CAS  Google Scholar 

  31. Relea P, Revilla M, Ripoll E, Arribas I, Villa LF, Rico H (1995) Zinc, biochemical markers of nutrition, and type I osteoporosis. Age Ageing 24:303–307

    Article  CAS  Google Scholar 

  32. Arikan DC, Coskun A, Ozer A, Kilinc M, Atalay F, Arikan T (2011) Plasma selenium, zinc, copper and lipid levels in postmenopausal Turkish women and their relation with osteoporosis. Biol Trace Elem Res 144:407–417

    Article  CAS  Google Scholar 

  33. Cervellati C, Bergamini CM (2016) Oxidative damage and the pathogenesis of menopause related disturbances and diseases. Clin Chem Lab Med 54:739–753

    Article  CAS  Google Scholar 

  34. Harisa GI (2015) Blood viscosity as a sensitive indicator for paclitaxel induced oxidative stress in human whole blood. Saudi Pharm J 23:48–54

    Article  Google Scholar 

  35. Bajada S, Yoong AWH, Hourigan P, Koopmans PC, Phillips JRA, Toms AD (2019) Plasma viscosity has a role in the diagnosis of prosthetic joint infection after total knee arthroplasty. J Arthroplasty 34:3035–3039

    Article  Google Scholar 

  36. Teng Z, Pei L, Zhang Y, Li Y, Wang R (2013) Whole blood viscosity is negatively associated with bone mineral density in postmenopausal women with osteoporosis. Bone 56:343–346

    Article  Google Scholar 

  37. Miller SA, Dykes DD, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215

    Article  CAS  Google Scholar 

  38. Ozcelik D, Tuncdemir M, Ozturk M, Uzun H (2011) Evaluation of trace elements and oxidative stress levels in the liver and kidney of streptozotocin-induced experimental diabetic rat model. Gen Physiol Biophys 30:356–363

    Article  CAS  Google Scholar 

  39. Alkan FA, Cakmak G, Karis D, Sağlam ZA, Saler T, Temiz LU, Yenigün M, Ercan M (2014) The evaluation of plasma viscosity and endothelial dysfunction in smoking individuals. Clin Hemorheol Microcirc 58:403–413

    Article  CAS  Google Scholar 

  40. Miao L, Clair DKS (2009) Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 47:344–356

    Article  CAS  Google Scholar 

  41. Nielsen FH, Lukaski HC, Johnson LK, Roughead ZKF (2011) Reported zinc, but not copper, intakes influence whole-body bone density, mineral content and T score responses to zinc and copper supplementation in healthy postmenopausal women. Br J Nutr 106:1872–1879

    Article  CAS  Google Scholar 

  42. Sadeghi N, Oveisi MR, Jannat B, Hajimahmoodi M, Behzad M, Behfar A, Sadeghi F, Saadatmand S (2014) The relationship between bone health and plasma zinc, copper lead and cadmium concentration in osteoporotic women. J Environ Heal Sci Eng 12:1–5

    Google Scholar 

  43. Rajeswaran C, Spencer J, Barth JH, Orme SM (2007) Utility of biochemical screening in the context of evaluating patients with a presumptive diagnosis of osteoporosis. Clin Rheumatol 26:362–365

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Designed the study: A.S., F.D.; collected samples: M.O.; determined polymorphism: F.D., D.T.C., and A.S.; measured element: MB; measured viscosity: A.S., D.D.E.; all authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Ahu Soyocak.

Ethics declarations

Ethical Approval

The study protocol complied with the ethical guideline for the 2013 Declaration of Helsinki and was approved by the Istanbul Aydin University Ethical Committee (Ethic No: B.30.2.AYD.0.00.00–050.06.04/590).

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Soyocak, A., Doganer, F., Duzgun Ergun, D. et al. Evaluation of Relationship Between SOD1 50-bp Deletion Gene Polymorphism, Cu, Zn Level, and Viscosity in Postmenopausal Osteoporosis Patients with Vertebral Fractures. Biol Trace Elem Res 201, 603–610 (2023). https://doi.org/10.1007/s12011-022-03185-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-022-03185-8

Keywords

Navigation